Used primarily in pharmaceutical research as an intermediate in the synthesis of bioactive compounds. Its fluorinated indazole core structure shows potential in the development of kinase inhibitors and other targeted therapies for cancer. The compound is also investigated for its role in enhancing metabolic stability and binding affinity in drug candidates. Due to its specific substitution pattern, it serves as a building block in medicinal chemistry for optimizing lead compounds in neurodegenerative and inflammatory disease research.